RxDoctor Payments Data

Hillary Hartung, PA

Physician Assistant · Norfolk, VANPI 1144740614

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $48,115 of the $61,605 with a category attached, or 78.1%. Viiv Healthcare Company accounts for 70.5% of it on its own, with 1 other manufacturer making up the rest. Among physician assistant clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$61,605in general payments, 2019–2025

Across 199 payments — averaging $309.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$43K
  • Gilead$18K

What the payments were for

  • Speaking & faculty fees$48,11578%
  • Travel & lodging$6,10010%
  • Food & beverage$7,39012%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Viiv Healthcare Company147$43,423
Gilead52$18,182

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$61,605 in reported general payments places this provider in the 95th percentile of 3,376 physician assistant providers in Virginia.

See all physician assistant providers in Virginia

Medicare billing

Part B allowed, 2024
$17,681
Medicare patients
85
Services billed
187

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala719$2,952,322
GenvoyaElviteg/Cob/Emtri/Tenof Alafen174$706,912
DovatoDolutegravir Sodium/Lamivudine229$673,513
OdefseyEmtricitab/Rilpiviri/Tenof Ala148$540,411
SymtuzaDarunavir/Cob/Emtri/Tenof Alaf116$533,256
TivicayDolutegravir Sodium196$483,712
DescovyEmtricitabine/Tenofov Alafenam151$355,555
JulucaDolutegravir/Rilpivirine81$280,933
TriumeqAbacavir/Dolutegravir/Lamivudi46$177,642
PifeltroDoravirine21$53,929
PrezistaDarunavir23$49,302
IsentressRaltegravir Potassium24$45,487
IntelenceEtravirine14$20,970
Atovaquone13$10,845
Ritonavir30$4,744

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadBiktarvy, Genvoya, Descovy$18,182$4,014,7891,044 claims
Viiv Healthcare CompanyDovato, Tivicay, Juluca, Triumeq$43,423$1,615,800552 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,376 physician assistant providers in Virginia.

Other physician assistant in Norfolk

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →